InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,346.99
(
-0.11%
)
US TECH 100
18,484.80
(
-0.27%
)
Dow Jones
38,798.99
(
-0.22%
)
Brent Oil
79.40
(
-0.61%
)
Bitcoin
69,227.97
(
-2.17%
)
Post# of 689
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

mulletman99

Send PM Follow Ignore
Followers 0
Posts 63
Boards Moderated 0
Alias Born 02/12/2011

mulletman99

Re: None

Wednesday, 02/06/2013 9:55:47 PM

Wednesday, February 06, 2013 9:55:47 PM

Post# of 689
Aegis Capital released a 2-3 page write-up on PYMX today.


They wrote an analyst report for Cubist. In ocvering their competition, they wrote an extremely long, extremely detailed description of the science and clinical trial data of 30063. Unusual to go into this much description of a competitor in an analyst report....in my opinion.

Here is the detail on the yoohoo message board.

http://finance.yahoo.com/mbview/threadview/?&bn=bcbe7017-fc7a-39e9-bde8-1f49e57e2e49&tid=1360173972416-d9f7f7b2-1d50-49eb-9825-cf0528d69461&tls=la%2Cd%2C0
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up